BioNTech SE (BNTX) Balance Sheet Quarterly

BioNTech SE

BNTX (NASDAQ)

(%)

Financials
BioNTech SE Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of EUR

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-03	2025-08-04	2025-03-31	2024-12-31	2024-09-30	2024-06-30	1234
Total Current Assets	15,831	15,929	15,626	18,804	18,486	18,282	1234
Cash and Short Term Investments	14,528	14,037	14,110	16,784	16,709	17,296	1234
Cash & Equivalents	10,093	10,270	10,185	9,762	9,625	10,377	1234
Short Term Investments	4,435	3,767	3,925	7,022	7,085	6,919	1234
Receivables	699.7	1,447	1,027	1,524	1,198	286.5	1234
Inventory	225.7	230.7	254.4	283.3	303.1	340.1	1234
Other Current Assets	377.7	215	234.3	212.7	275.8	359.3	1234
Total Assets	21,341	21,638	21,182	22,530	22,401	22,238	1234
Total Non-Current Assets	5,510	5,708	5,557	3,726	3,915	3,956	1234
Property, Plant and Equipment	1,241	1,242	1,268	1,183	1,159	1,125	1234
Goodwill and Intangible Assets	1,748	1,851	1,887	1,171	1,248	1,235	1234
Goodwill	357.7	364.1	375.9	380.6	374	372.4	1234
Intangible Assets	1,390	1,487	1,511	790.4	873.9	862.3	1234
Long Term Investments	2,476	2,505	2,286	1,254	1,332	1,386	1234
Deferred Tax Assets	0	77.8	85.5	81.7	90.7	102.3	1234
Other Long Term Assets	46.2	32.7	30.5	36.1	84.8	108.2	1234
Total Current Liabilities	2,222	1,851	1,534	2,523	2,522	2,426	1234
Accounts Payable	399.8	504.2	443.8	426.7	762.6	881.5	1234
Notes Payable/Short Term Debt	53.4	52.4	55.5	39.5	37.4	35.3	1234
Tax Payables	0	3.7	5.4	4.5	363.6	365.2	1234
Deferred Revenue	0	945.4	294.5	294.9	236	474.3	1234
Other Current Liabilities	1,769	345.1	735.3	1,758	1,123	669.6	1234
Total Liabilities	2,864	3,132	2,256	3,119	3,287	3,166	1234
Total Non-Current Liabilities	641.3	1,282	721.3	595.4	764.2	739.7	1234
Total Long Term Debt	192	217.2	237.5	214.7	206.3	219.3	1234
Deferred Tax Liabilities Non-Current	0	28.5	44.1	42.4	37.8	37.8	1234
Deferred Revenue Non-Current	0	787.7	182.9	183	376.9	353.6	1234
Capital Lease Obligations	207	0	0	0	0	0	1234
Other Long Term Liabilities	242.3	248.3	256.8	155.3	143.2	129	1234
Total Equity	18,477	18,505	18,927	19,411	19,114	19,072	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	18,477	18,505	18,927	19,411	19,114	19,072	1234
Retained Earnings	18,267	18,296	18,682	19,098	18,838	18,640	1234
Accumulated Other Earnings	-30.1	-1,479	-1,443	-1,326	-1,337	-1,038	1234
Common Stock	248.6	248.6	248.6	248.6	248.6	248.6	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	-8.1	1,440	1,439	1,390	1,364	1,222	1234
Total Liabilities & Total Equity	21,341	21,638	21,182	22,530	22,401	22,238	1234
Total Liabilities & Shareholders' Equity	21,341	21,638	21,182	22,530	22,401	22,238	1234
Total Investments	6,911	6,272	6,211	8,276	8,417	8,305	1234
Total Debt	245.4	269.6	293	254.2	243.7	254.6	1234
Net Debt	-9,848	-10,000	-9,892	-9,508	-9,381	-10,122	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

BioNTech SE Balance Sheet Statement Quarterly